Cancer Outcomes and Services Data Set - Central Nervous System

Cancer Outcomes and Services Data Set Overview

Due to the rapidly changing situation with Covid-19, the implementation date of the Cancer Outcomes and Services Data Set (COSDS) has been deferred until 1 July 2020.

This will be reviewed and continued to be moved forward 3 months until there is a stable position nationally to resume the upgrade process.

For further information please contact: COSD@phe.gov.uk.

The previous version of the data set can be found at: COSDS Data Sets

For a "Full Screen" view, click Cancer Outcomes and Services Data Set: Central Nervous System.

In the "Full Screen" view, to return to the "Data Set" view, click the browser "back" button. 

The Mandatory or Required (M/R) column in the COSDS XML Schema indicates the recommendation for the inclusion of data.

For guidance on downloading the XML Schema, see XML Schema TRUD Download.

For guidance on the XML Schema constraints, see the Cancer Outcomes and Services Data Set XML Schema Constraints.

IMAGING - CENTRAL NERVOUS SYSTEM (CNS)

To carry imaging details for Central Nervous System (CNS) cancer.
One occurrence of this group is permitted per Core Imaging.
M/RData Set Data Elements
RLESION LOCATION (RADIOLOGICAL)
RNUMBER OF LESIONS (RADIOLOGICAL)
RLESION SIZE (RADIOLOGICAL)
RPRINCIPAL DIAGNOSTIC IMAGING TYPE

CANCER CARE PLAN - CENTRAL NERVOUS SYSTEM (CNS)

To carry cancer care plan details for Central Nervous System (CNS) cancer.
One occurrence of this group is permitted Core Cancer Care Plan.
M/RData Set Data Elements
RPROVISIONAL DIAGNOSIS (ICD)

SURGERY - TREATMENT - CENTRAL NERVOUS SYSTEM (CNS)

To carry surgery details for Central Nervous System (CNS) cancer.
One occurrence of this group is permitted per Core Treatment Surgery.
M/RData Set Data Elements
RTUMOUR LOCATION (SURGICAL)
RBIOPSY TYPE (CENTRAL NERVOUS SYSTEM TUMOURS)
REXCISION TYPE (CENTRAL NERVOUS SYSTEM TUMOURS)

SURGERY - TREATMENT: CHILDREN, TEENAGERS AND YOUNG ADULTS (CTYA) - CENTRAL NERVOUS SYSTEM (CNS)

To carry surgery  details for Children, Teenagers and Young Adults (CTYA) for Central Nervous System (CNS) cancer.
One occurrence of this group is permitted per Core Treatment Surgery.
M/RData Set Data Elements
RRESECTION STATUS

DIAGNOSIS: LOW GRADE GLIOMA - CENTRAL NERVOUS SYSTEM (CNS)

To carry diagnostic Low Grade Glioma details for Central Nervous System (CNS) cancer.
One occurrence of this group is permitted per Core Diagnosis
.
M/RData Set Data Elements
RVISUAL ACUITY TEST RESULT (AT DIAGNOSIS)
Multiple occurrences of this item are permitted
RVISUAL FIELD TEST RESULT (AT DIAGNOSIS)
Multiple occurrences of this item are permitted

SITE SPECIFIC STAGING: CEREBROSPINAL FLUID (CSF) - CENTRAL NERVOUS SYSTEM (CNS)

To carry site specific staging Cerebrospinal Fluid (CSF) details for Central Nervous System (CNS) cancer.
One occurrence of this group is required per Core Site Specific Staging.
M/RData Set Data Elements
MCHANG STAGING SYSTEM STAGE

LABORATORY RESULTS: GERM CELL CENTRAL NERVOUS SYSTEM (CNS) TUMOURS CHOICE - CENTRAL NERVOUS SYSTEM (CNS)

One occurrence of this group is permitted per Core Laboratory Results
One of the following Germ Cell Central Nervous System (CNS) tumour laboratory result details MUST be provided per Core Laboratory Results
CHOICE 1 - ALPHA FETOPROTEIN
To carry Germ Cell Central Nervous System (CNS) tumour laboratory result details.
One occurrence of this group is required per Core Laboratory Results if selected as the choice
.
M/RData Set Data Elements
MALPHA FETOPROTEIN (CEREBROSPINAL FLUID)
OR
CHOICE 2 - BETA HUMAN CHORIONIC GONADOTROPIN
To carry Germ Cell Central Nervous System (CNS) tumour laboratory result details.
One occurrence of this group is required per Core Laboratory Results if selected as the choice
.
M/RData Set Data Elements
MBETA HUMAN CHORIONIC GONADOTROPIN (CEREBROSPINAL FLUID)